Trial Holdings Inc
141A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.95 | 0.71 | 2.00 | 0.10 |
| FCF Yield | -13.61% | 14.02% | 0.79% | 3.51% |
| EV / EBITDA | 7.37 | 6.08 | 8.40 | 12.25 |
| Quality | ||||
| ROIC | 7.26% | 8.39% | 8.63% | 8.11% |
| Gross Margin | 20.78% | 20.11% | 17.93% | 17.32% |
| Cash Conversion Ratio | -0.38 | 5.20 | 2.28 | 3.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.16% | 6.42% | 60.70% | 84,234,739.82% |
| Free Cash Flow Growth | -204.24% | 2,066.02% | -81.88% | 231.55% |
| Safety | ||||
| Net Debt / EBITDA | -1.00 | -2.46 | -0.17 | -0.14 |
| Interest Coverage | 301.51 | 217.74 | 123.58 | 87.93 |
| Efficiency | ||||
| Inventory Turnover | 11.29 | 12.39 | 11.38 | 12.27 |
| Cash Conversion Cycle | -13.37 | -34.54 | -17.07 | -18.69 |